4404 Bispecific Antibody
搜索文档
Pfizer Inc. (PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology - Slideshow (NYSE:PFE) 2025-11-10
Seeking Alpha· 2025-11-11 10:32
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...